These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33400818)

  • 61. Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.
    Hori Y; Seo S; Yoh T; Ueno K; Morino K; Toda R; Nishio T; Koyama Y; Fukumitsu K; Ishii T; Hata K; Masui T; Taura K; Hatano E
    Ann Surg Oncol; 2022 Oct; 29(11):6745-6754. PubMed ID: 35691953
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification.
    Iacuzzo C; Germani P; Troian M; Cipolat Mis T; Giudici F; Osenda E; Bortul M; de Manzini N
    ANZ J Surg; 2021 Jun; 91(6):E367-E374. PubMed ID: 33870621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
    Sasaki K; Morioka D; Conci S; Margonis GA; Sawada Y; Ruzzenente A; Kumamoto T; Iacono C; Andreatos N; Guglielmi A; Endo I; Pawlik TM
    Ann Surg; 2018 Jan; 267(1):132-141. PubMed ID: 27763897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.
    Haruki K; Shiba H; Horiuchi T; Sakamoto T; Gocho T; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
    Am J Surg; 2017 Oct; 214(4):752-756. PubMed ID: 28187858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.
    Girard P; Ducreux M; Baldeyrou P; Rougier P; Le Chevalier T; Bougaran J; Lasser P; Gayet B; Ruffié P; Grunenwald D
    J Clin Oncol; 1996 Jul; 14(7):2047-53. PubMed ID: 8683235
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis.
    de Jong MC; van Vledder MG; Ribero D; Hubert C; Gigot JF; Choti MA; Schulick RD; Capussotti L; Dejong CH; Pawlik TM
    J Gastrointest Surg; 2011 Feb; 15(2):336-44. PubMed ID: 21108017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
    Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
    Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
    Brudvik KW; Jones RP; Giuliante F; Shindoh J; Passot G; Chung MH; Song J; Li L; Dagenborg VJ; Fretland ÅA; Røsok B; De Rose AM; Ardito F; Edwin B; Panettieri E; Larocca LM; Yamashita S; Conrad C; Aloia TA; Poston GJ; Bjørnbeth BA; Vauthey JN
    Ann Surg; 2019 Jan; 269(1):120-126. PubMed ID: 28549012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome.
    Tocchi A; Mazzoni G; Brozzetti S; Miccini M; Cassini D; Bettelli E
    Int J Colorectal Dis; 2004 Nov; 19(6):580-5. PubMed ID: 15103491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
    Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
    Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases.
    Imai K; Yamashita YI; Miyamoto Y; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Baba H
    Int J Clin Oncol; 2018 Oct; 23(5):908-916. PubMed ID: 29619592
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
    Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
    Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis.
    Okimoto S; Kobayashi T; Tashiro H; Kuroda S; Ishiyama K; Ide K; Abe T; Hashimoto M; Iwako H; Hamaoka M; Honmyo N; Yamaguchi M; Ohdan H
    Int J Surg; 2017 Jun; 42():209-214. PubMed ID: 28483664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.